{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:44:57Z","timestamp":1725835497955},"reference-count":16,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is much interest in the possibility that prolactin influences disease activity in systemic lupus erythematosus (SLE). We present the first reported pediatric case of prolactinoma associated with SLE, in a 13\u2010year\u2010old white female. The diagnosis of SLE was based on the presence of arthritis, antinuclear antibodies, and double\u2010stranded DNA, and a chest radiograph showing pleural fluid. The diagnosis of pituitary prolactinoma was based on the histologic features and the presence of amenorrhea, galactorrhea, and an elevated serum prolactin level. Neurosurgical resection and medical therapy with bromocriptine mesylate were independently associated with decreased prolactin levels, loss of arthritis, and reduced levels of inflammatory mediators.<\/jats:p>","DOI":"10.1002\/art.20751","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T21:26:48Z","timestamp":1100294808000},"page":"3616-3618","source":"Crossref","is-referenced-by-count":11,"title":["First reported pediatric case of systemic lupus erythematosus associated with prolactinoma"],"prefix":"10.1002","volume":"50","author":[{"given":"Peter D.","family":"Reuman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"e_1_2_4_2_2","first-page":"1833","volume-title":"The physiology of reproduction","author":"Neill JD","year":"1994"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-215-44111"},{"key":"e_1_2_4_4_2","first-page":"639","article-title":"Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects","volume":"17","author":"Ben\u2010Jonathan N","year":"1996","journal-title":"Endocr Rev"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09615.x"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301717164994"},{"key":"e_1_2_4_7_2","first-page":"479","article-title":"Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma","volume":"16","author":"Funauchi M","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301701549688"},{"key":"e_1_2_4_9_2","first-page":"2140","article-title":"Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus: effect of conventional treatment","volume":"30","author":"Vera\u2010Lastra O","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(02)00081-2"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301717164985"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu487oa"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00918091"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301717165010"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01452255"},{"key":"e_1_2_4_17_2","first-page":"1227","article-title":"Prolactinomas in children and adolescents: consequences in adult life","volume":"14","author":"Duntas LH","year":"2001","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.20751","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.20751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:50:18Z","timestamp":1697521818000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.20751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1002\/art.20751"],"URL":"https:\/\/doi.org\/10.1002\/art.20751","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}